Myeloid or type 1 dendritic cell leukaemia is an exceedingly rare haematopoietic neoplasm characterized by a specific immunophenotypic profile close to plasmacytoid dendritic cell and acute myelogenous leukaemia. A 77-year-old man presenting specific cutaneous infiltration by myeloid dendritic cell leukaemia is reported. The clinical features as well as the cutaneous histopathological and immunohistochemical features led to the initial diagnosis of CD4+/CD56+ haematodermic neoplasm. However, extensive immunophenotypic studies performed from peripheral blood blasts disclosed that leukaemic cells expressed myeloid dendritic cell markers, confirming the diagnosis. The diagnostic difficulties of specific cutaneous involvement by myeloid dendritic cell leukaemia on the basis of routine histopathological and immunohistochemical features are highlighted.

References

1 Jacob MC, Chaperot L, Mossuz P et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88: 941–55.
PubMed Web of Science® Google Scholar
2 Bueno C, Almeida J, Lucio P et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 2004; 89: 58–69.
CAS PubMed Web of Science® Google Scholar
3 Willemze R, Jaffe ES, Burg G et al. WHO–EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–85.
10.1182/blood-2004-09-3502
CAS PubMed Web of Science® Google Scholar
4 Chaperot L, Bendriss N, Manches O et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210–17.
10.1182/blood.V97.10.3210
CAS PubMed Web of Science® Google Scholar
5 Petrella T, Bagot M, Willemze R et al. Blastic NK-cell lymphomas (agranular CD4+ CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005; 123: 662–75.
10.1309/GJWNPD8HU5MAJ837
PubMed Web of Science® Google Scholar
6 Feuillard J, Jacob MC, Valensi F et al. Clinical and biologic features of CD4(+) CD56(+) malignancies. Blood 2002; 99: 1556–63.
10.1182/blood.V99.5.1556
CAS PubMed Web of Science® Google Scholar
7 Petrella T, Comeau MR, Maynadie M et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852–62.
10.1097/00000478-200207000-00003
PubMed Web of Science® Google Scholar
8 Aguilar H, Alvarez-Errico D, Garcia-Montero A et al. Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol 2004; 173: 6703–11.
10.4049/jimmunol.173.11.6703
CAS PubMed Web of Science® Google Scholar
9 Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukaemia and blastic NK cell lymphoma/leukaemia. Leuk Res 1999; 23: 615–24.
10.1016/S0145-2126(98)00194-5
CAS PubMed Web of Science® Google Scholar
10 Inaba T, Shimazaki C, Sumikuma T et al. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukaemia. Leuk Res 2001; 25: 109–13.
10.1016/S0145-2126(00)00099-0
CAS PubMed Web of Science® Google Scholar
11 Sun T, Pashaei S, Jaffrey I, Ryder J. A hybrid form of myeloid/NK-cell acute leukaemia and myeloid/NK-cell precursor acute leukaemia. Hum Pathol 2003; 34: 504–8.
10.1016/S0046-8177(03)00087-X
PubMed Web of Science® Google Scholar
12 Scott AA, Head DR, Kopecky KJ et al. HLA-DR–, CD33+, CD56+, CD16− myeloid/natural killer cell acute leukaemia: a previously unrecognized form of acute leukaemia potentially misdiagnosed as French–American–British acute myeloid leukemia–M3. Blood 1994; 84: 244–55.
CAS PubMed Web of Science® Google Scholar
13 Tanaka M. Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia. J Eur Acad Dermatol Venereol 2006; 20: 453–6.
10.1111/j.1468-3083.2006.01491.x
PubMed Web of Science® Google Scholar
14 Lichtman MA, Segel GB. Uncommon phenotypes of acute myelogenous leukaemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review. Blood Cells Mol Dis 2005; 35: 370–83.
10.1016/j.bcmd.2005.08.006
CAS PubMed Web of Science® Google Scholar
15 Beyer V, Muhlematter D, Parlier V et al. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Cancer Genet Cytogenet 2005; 160: 97–119.
10.1016/j.cancergencyto.2004.12.003
CAS PubMed Web of Science® Google Scholar
16 Sen F, Zhang XX, Prieto VG et al. Increased incidence of trisomy 8 in acute myeloid leukaemia with skin infiltration (leukaemia cutis). Diagn Mol Pathol 2000; 9: 190–4.
10.1097/00019606-200012000-00003
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume158, Issue5

May 2008

Pages 1129-1133

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge

Summary

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge

Summary

References

Citing Literature

References

Related

Information